Ad is loading...
LMVYX
Price
$32.57
Change
-$0.27 (-0.82%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

LMVYX vs VISVX

Header iconLMVYX vs VISVX Comparison
Open Charts LMVYX vs VISVXBanner chart's image
Lord Abbett Focused Small Cap Value I
Price$32.57
Change-$0.27 (-0.82%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
LMVYX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LMVYX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LMVYX is a Buy and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. LMVYX (107M). VISVX pays higher dividends than LMVYX: VISVX (1.90) vs LMVYX (0.23). LMVYX was incepted earlier than VISVX: LMVYX (25 years) vs VISVX (27 years). LMVYX is a more actively managed with annual turnover of: 54.00 vs. VISVX (16.00). VISVX has a lower initial minimum investment than LMVYX: VISVX (3000) vs LMVYX (1000000). VISVX (28.71) and LMVYX (28.57) have marching annual gain over last year. VISVX return over 5 years is better than : 57.32 vs. LMVYX (16.24).
LMVYXVISVXLMVYX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years27 years-
Gain YTD14.12115.43391%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets107M57.6B0%
Annual Yield % from dividends0.231.9012%
Returns for 1 year28.5728.71100%
Returns for 3 years-6.1013.23-46%
Returns for 5 years16.2457.3228%
Returns for 10 years-5.12108.21-5%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics